Barrington analyst Michael Petusky maintained a Buy rating on Tivity Health Inc (TVTY – Research Report) today and set a price target of $40. The company’s shares closed last Monday at $18.30, close to its 52-week low of $14.84.
According to TipRanks.com, Petusky is a 3-star analyst with an average return of 3.3% and a 47.5% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics Inc, Varian Medical Systems, and Merit Medical Systems.
Currently, the analyst consensus on Tivity Health Inc is a Moderate Buy with an average price target of $32.50, which is a 77.2% upside from current levels. In a report issued on August 8, Piper Jaffray also reiterated a Buy rating on the stock with a $25 price target.
Tivity Health Inc’s market cap is currently $865.3M and has a P/E ratio of 10.45. The company has a Price to Book ratio of 1.63.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tivity Health, Inc. engages in the development and provision of network solutions and health management services. It offers rehabilitative therapy, chiropractic procedure, alternative medicines, and health and fitness programs under the SilverSneakers, Prime Fitness, and WholeHealth Living trademarks.